Hologic clears regulatory hurdle in Canada for 2 HPV assays

04/8/2013 | GenomeWeb Daily News (free registration)

Hologic has obtained approval to market its Aptima HPV and Aptima HPV 16 18/45 tests in Canada. The genotype assays, which already have been approved by the FDA, work with the company's Tigris technology and are used to identify human papillomavirus strains that are linked to precancerous lesions and cervical cancer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX